# The Human Medicines (Amendment) Regulations 2023, Regulation 4: Amendment of regulation 49 (application for grant of UK marketing authorisation or parallel import licence)


In regulation 49(3)—
(a) for sub-paragraph (a) substitute—
“(a) a UKMA(UK) or UKMA(NI), must be established in the United Kingdom or an EEA State;”;
(b) in sub-paragraph (b)(ii), after “the United Kingdom” insert “or an EEA State”; and
(c) in sub-paragraph (c), for “UKMA(UK)” substitute “parallel import licence”.

---
Source: https://www.legislation.gov.uk/uksi/2023/437/regulation/4 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-regulations-2023/regulation-4
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.